Nykredit Realkredit A/S
To Nasdaq Copenhagen
11 January 2021
Nykredit’s and Totalkredit’s auctions for 1 April 2021 refinancing
The Nykredit Group conducts auctions in the period from Monday 8 February to Friday 12 February 2021. The auctions will comprise refinancing of adjustable-rate mortgages (”Tilpasningslån”) and floating-rate loans in DKK.
The Nykredit Group currently expects to sell bonds totalling up to DKK 28bn. The amounts are preliminary and will be affected by prepayments and refinancing changes until end January.
Time schedule
The auctions will be held according to the following schedule.
Auction period | Expected auction times – CET |
8 to 12 February |
First auction: Bidding until 10:30 / allotment 10:40 at latest Second auction: Bidding until 11:30 / allotment 11:40 at latest Third auction: Bidding until 13:00 / allotment 13:10 at latest |
Auction amounts and period
Details on auction amounts and period will be announced at the beginning of February. Subsequently, the auction amounts will be updated on an ongoing basis at nykredit.com/ir.
Contacts
Questions regarding the bond sales and technical matters may be addressed to Funding & Capital, Lars Mossing Madsen, tel +45 44 55 11 66.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
FLSmidth A/S9.7.2025 08:41:33 CEST | Press release
Correction to Company Announcement no. 15-2025: Transactions under share buy-back programme
Syensqo SA9.7.2025 08:30:00 CEST | Press release
Syensqo - Participation notification by BlackRock Inc.
Sparekassen Sjælland-Fyn A/S9.7.2025 08:13:26 CEST | Pressemeddelelse
SJF Bank opjusterer forventningerne til resultatet for 2025
Ekopak N.V.9.7.2025 08:10:24 CEST | Press release
Ekopak appoints Jean-Baptiste De Cuyper as new CEO
Purespring Therapeutics9.7.2025 08:00:00 CEST | Press release
Purespring Therapeutics announce FDA IND clearance for Phase I/II clinical trial for primary IgA nephropathy (IgAN)
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom